Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2026-03-19

DOI:

10.1073/pnas.2518080123

Affiliations:

7

Authors:

5

Go to article

Institutions	Authors	Share
Henry Ford Health System (HFHS), United States of America (USA)	1.333333	0.27
Oakland University, United States of America (USA)	1.000000	0.20
Translational Oncology (TRON), Germany	1.000000	0.20
Michigan State University (MSU), United States of America (USA)	0.666667	0.13
University of California, San Francisco (UCSF), United States of America (USA)	0.500000	0.10
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.500000	0.10

Interested in Immunology?